Urinary 8-hydroxy-2′-deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure

European Journal of Heart Failure

Volumn 13, Issue 1, 2011, Pages 29-36

  Kobayashi, Shigeki ^a   Susa, Takehisa ^a   Tanaka, Takeo ^a   Wada, Yasuaki ^a   Okuda, Shinichi ^a   Doi, Masahiro ^a   Nao, Tomoko ^a   Yoshiga, Yasuhiro ^a   Yamada, Jutaro ^a   Okamura, Takayuki ^a   Ueyama, Takeshi ^a   Kawamura, Syuji ^a   Yano, Masafumi ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; Heart failure; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AORTA ROOT; ARTICLE; CONTROLLED STUDY; CORONARY SINUS; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; SYSTOLIC DYSFUNCTION; URINE LEVEL;

AORTA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY SINUS; DEOXYGUANOSINE; DISEASE PROGRESSION; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PROGNOSIS; REACTIVE OXYGEN SPECIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 78650319507     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq178     Document Type: Article

References (41)

1. McMurray J Chopra M Abdullah I Smith WE Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 1993;14:1493-1498.
2. Kukin ML Kalman J Charney RH Levy DK Buchholz-Varley C Ocampo ON Eng C. Prospective randomized comparison of effect of long-term treatment with metoprolol or carvedilol or symptoms exercise ejection fraction and oxi-dative stress in heart failure. Circulation 1999;99:2645-2651.
3. Keith M Geranmayegan A Sole MJ Kurian R Robinson A Omran AS Jeejeebhoy KN. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998;31:1352-1356.
4. Nakamura K Kusano K Nakamura Y Kakishita M Ohta K Nagase S Yamamoto M Miyaji K Saito H Morita H Emori T Matsubara H Toyokuni S Ohe T. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 2002;105:2867-2871.
5. Kono Y Nakamura K Kimura H Nishii N Watanabe A Banba K Miura A Nagase S Sakuragi S Kusano KF Matsubara H Ohe T. Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure. Circ J 2006; 70:1001-1005.
6. Ide T Tsutsui H Hayashidani S Kang D Suematsu N Nakamura K Utsumi H Hamasaki N Takeshita A. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001;88: 529-535.
7. Tsutsui H Ide T Shiomi T Kang D Hayashidani S Suematsu N Wen J Utsumi H Hamasaki N Takeshita A. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 2001;104:2883-2885.
8. Sawyer DB Siwik DA Xiao L Pimentel DR Singh K Colucci WS. Role of oxi-dative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002;34: 379-388.
9. Nakamura K Fushimi K Kouchi H Mihara K Miyazaki M Ohe T Namba M. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 1998;98:794-799.
10. Xiao L Pimentel DR Wang J Singh K Colucci WS Sawyer DB. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 2002;282:C926-C934.
11. Cheng TH Shih NL Chen SY Wang DL Chen JJ. Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc Res 1999;41:654-662.
12. Amin JK Xiao L Pimentel DR Pagano PJ Singh K Sawyer DB Colucci WS. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocyte. J Mol Cell Cardiol 2001;33:131-139.
13. Cai J Jones DP. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 1998;273:11401-11404.
14. Zima AV Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006;71:310-321.
15. Yano M Okuda S Oda T Tokuhisa T Tateishi H Mochizuki M Noma T Doi M Kobayashi S Yamamoto T Ikeda Y Ohkusa T Ikemoto N Matsuzaki M. Correction of defective interdomain interaction within ryanodine receptor by antioxi-dant is a new therapeutic strategy against heart failure. Circulation 2005;112: 3633-3643.
16. Mochizuki M Yano M Oda T Tateishi H Kobayashi S Yamamoto T Ikeda Y Ohkusa T Ikemoto N Matsuzaki M. Scavenging free radicals by low-dose carve-dilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure. J Am Coll Cardiol 2007;49:1722-1732.
17. Zimmet JM Hare JM. Nitroso-redox interaction in the cardiovascular system. Circulation 2006;114:1531-1544.
18. Tsutamoto T Wada A Matsumoto T Maeda K Mabuchi N Hayashi M Tsutsui T Ohnishi M Sawaki M Fujii M Matsumoto T Yamamoto T Horie H Sugimoto Y Kinoshita M. Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy. J Am Coll Cardiol 2001;37:2086-2092.
19. Tang WHW Tong W Troughton RW Martin MG Shrestha K Borowski A Jasper S Hazen SL Klein AL. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J Am Coll Cardiol 2007;49:2364-2370.
20. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-2159.
21. Bergamini C Cicoira M Rossi A Vassanelli V. Oxidative stress and hyperuricae-mia: pathophysiology clinical relevance andtherapeutic implications in chronic heart failure. Eur J Heart Fail 2009;11:444-452.
22. Banfi C Brioschi M Barcella S Veglia F Biglioli P Tremoli E Agostoni PG. Oxidized proteins in plasma of patients with heart failure: role in endothelial damage. Eur J Heart Fail 2008;10:244-251.
23. Eleuteri E Magno F Gnemmi I Carbone M Colombo M La Rocca G Anzalone R Genta FT Zummo G Di Stefano A Giannuzzi P. Role of oxidative and nitrosative stress biomarkers in chronic heart failure. Front Biosci 2009;14:2230-2237.
24. Wu LL Chiou CC Chang PY Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer atherosclerosis and diabetics. Clin Chim Acta 2004;339:1-9.
25. Kasai H. Chemistry-based studies on oxidative DNA damage: formation repair and mutagenesis. Free Radic Biol Med 2002;33:450-456.
26. ′-deoxyguanosine a marker of oxidized DNA damage during aging. Mutat Res 1996;316:277-285.
27. Ames BN. Endogenous oxidative DNA damage aging and cancer. Free Radical Res Commun 1989;7:121-128.
28. Loft S Vistisen K Ewertz M Tjonneland A Overvad K Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking gender and body mass index. Carcinogenesis 1992;13: 2241-2247.
29. Sakumi K Furuichi M Tsuzuki T Kakuma T Kawabata S Maki H Sekiguchi M. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP a mutagenic substrate for DNA synthesis. J Biol Chem 1993;268: 524-530.
30. Leinonen J Lehtimäki T Toyokuni S Okada K Tanaka T Hiai H Ochi H Laippala P Rantalaiho V Wirta O Pasternack A Alho H. New biomarker evidence of oxidative DNA damage in patients with noninsulin dependent diabetes mellitus. FEBS Lett 1997;417:150-152.
31. Richardson P McKenna W Bristow M Maisch B Mautner B O'Connell J Olsen E Thiene G Goodwin J Gyarfas I Martin I Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93:841-842.
32. Shikano M Sobajima H Yoshikawa H Toba T Kushimoto H Katsumata H Tomita M Kawashima S. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 2000;85:81-85.
33. Kashiwagi M Shinozaki M Hirakata H Tamaki K Tadashi H Tokumoto M Goto H Okuda S Fujishima M. Locally activated rennin-angiotensin system associated with TGF-b1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats. J Am Soc Nephrol 2003;11: 616-624.
34. Jug B Salobir BG Vene N Sebestjen M Sabovic M Keber I. Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart Vessels 2009;24:271-276.
35. Castro PF Greig D Perez O Moraga F Chiong M Diaz-Araya G Padilla I Nazzal C Jalil JE Vukasovic JL Moreno M Corbalán R Lavandero S. Relation between oxidative stress catecholamines and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idio-pathic dilated cardiomyopathy. Am J Cardiol 2003;92:215-218.
36. Hayashi M Tsutamoto T Wada A Maeda K Mabuchi N Tsutsui T Horie H Ohnishi M Kinoshita M. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 2001;37:1820-1826.
37. Maeda K Tsutamoto T Wada A Mabuchi N Hayashi M Tsutsui T Ohnishi M Sawaki M Fujii M Matsumoto T Kinoshita M. High levels of plasma brain natriure-tic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1587-1593.
38. Kitakaze M Asakura M Kim J Shintani Y Asanuma H Hamasaki T Seguchi O Myoishi M Minamino T Ohara T Nagai Y Nanto S Watanabe K Fukuzawa S Hirayama A Nakamura N Kimura K Fujii K Ishihara M Saito Y Tomoike H Kitamura S J-WIND investigators. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 2007;370:1483-1493.
39. Ogawa S Mori T Nako K Ito S. Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy. Hypertens Res 2008;31:1147-1155.
40. Sakano N Wang DH Takahashi N Wang B Sauriasari R Kanbara S Sato Y Takigawa T Takaki J Ogino K. Oxidative stress biomarkers and lifestyles in Japanese healthy people. J Clin Biochem Nutr 2009;44:185-195.
41. Akagi S Nagake Y Kasahara J Sarai A Kihara T Morimoto H Yano A Nakao K Nanba K Ichikawa H Makino H. Significance of 8-hydroxy-2'-deoxyguanosine levels in patients with chronic renal failure. Nephrology 2003;8:192-195.